Nicole McNeil is counsel in the London office and a member of the Public Company Representation Practice, focusing on general securities, corporate governance, and public reporting matters.

Nicole is experienced in advising a broad range of public companies on corporate governance, reporting, and disclosure issues, including compliance with:

  • New York Stock Exchange and Nasdaq Corporate Governance Rules
  • Periodic and Current Reporting Requirements
  • Proxy Rules
  • Insider Reporting Obligations and Trading Restrictions
  • Sarbanes-Oxley

Her clients include both US and foreign New York Stock Exchange and Nasdaq-listed companies across a broad range of industries, with a particular focus on life sciences, technology, and retail.

Nicole also has experience representing public and private companies and underwriters in a variety of financing transactions, including initial public offerings and venture financings.

Nicole’s representative public company clients have included:

  • Abcam
  • Atai Life Sciences
  • Evelo Biosciences
  • Farfetch
  • Fiverr
  • Galera Therapeutics 
  • HeadHunter
  • Homology Medicines
  • Merus
  • PureTech Health
  • Rhythm Pharmaceuticals
  • Seres Therapeutics
  • Sportradar
  • Oatly
  • Vertical Aerospace
  • Verona Pharma
  • Zentalis Pharmaceuticals

Bar Qualification

  • Massachusetts

Education

  • JD, Cornell Law School, 2014
  • BA, Williams College, 2009

Languages Spoken

  • English
Abstract blue light and shade triangle shape creative background illustration.
August 25, 2025 Recognition

Latham Leads H1 2025 Capital Markets League Tables

Firm’s Capital Markets Practice once again earns top legal advisor league table rankings across debt and equity products and industries globally in Bloomberg, Dealogic, Deal Point Data, and LSEG.